A Guide To Pharmaceutical Serialization And Track-And-Trace Requirements

The Drug Supply Chain Security Act, known as DSCSA, established the federal framework behind pharmaceutical serialization and track-and-trace requirements in the United States. Congress passed the law in 2013 to give the pharmaceutical supply chain a way to track individual drug packages from the point of manufacture to the pharmacy counter, closing the gaps that let counterfeit, stolen, or otherwise compromised medications slip into circulation. For anyone managing a pharmaceutical supply chain, from a regional distributor to a hospital pharmacy operations team, understanding who does what under this law matters as much as understanding the law itself.

That distinction, who is actually responsible for what, is where a lot of confusion sets in. Serialization and verification obligations sit with specific parties defined in the statute. A courier or transport partner supporting that chain plays a different role entirely, one that matters just as much but works under a different set of rules.

What Is Pharmaceutical Serialization?

Serialization means applying a unique product identifier to every saleable unit of a prescription drug. That identifier combines the National Drug Code, a lot number, an expiration date, and a serial number unique to that specific package. Under DSCSA, this unit-level identifier is what makes package-level tracing possible instead of relying on lot-level records alone, and it has to appear on nearly every prescription drug moving through the U.S. supply chain in finished dosage form.

Who Is Responsible for Serialization and Track-and-Trace Compliance?

The FDA assigns drug supply chain security act compliance to four specific groups: manufacturers, repackagers, wholesale distributors, and dispensers, primarily pharmacies. These are the trading partners named directly in the statute, and each one carries distinct obligations for applying, verifying, and passing along transaction data as product moves through their hands. A regional courier or final-mile transport provider does not fall into any of these four categories and does not serialize, verify, or report on drug products under DSCSA. That distinction is worth keeping straight, since it shapes what a logistics vendor can and cannot claim about its own role in a compliant chain.

What Is EPCIS and Why Does It Matter for Track-and-Trace?

EPCIS, or Electronic Product Code Information Services, is the interoperable data standard the FDA points to for exchanging transaction information between trading partners electronically. It gives manufacturers, distributors, and dispensers a common format for sharing package-level data, which is what makes real-time tracing across multiple companies possible instead of relying on separate systems that do not talk to each other.

How Does Track-and-Trace Work Across the Supply Chain?

Picture a single package moving from a manufacturer to a wholesale distributor and finally to a dispenser. At each handoff, the sending party has to pass along transaction information tied to that unique product identifier, and the receiving party has to confirm it matches before accepting the shipment. Wholesale distributor requirements include verifying saleable returns before they go back into inventory, and any dispenser that receives a suspect product has to quarantine it and investigate before it goes anywhere near a patient. That verification loop, repeated at every handoff, is what suspect product verification actually looks like in practice.

Where Does Transport and Chain of Custody Fit Into a Compliant Supply Chain?

Transport sits alongside this system rather than inside it. A courier moving pharmaceuticals between authorized trading partners does not apply, verify, or report a product identifier, but a documented, temperature-controlled handoff still supports the chain of custody that DSCSA compliance depends on. Pillow Logistics operates in that supporting role for pharmaceutical shipments, using a CJIS-cleared driver network and documented chain-of-custody handoffs to keep product accountable between the time it leaves one trading partner’s hands and arrives at the next. Ambient, refrigerated, and frozen segregation protects product integrity throughout that transport window, which matters just as much to a distributor’s compliance picture as the electronic data exchange happening around it.

What Should You Look for in a Logistics Partner Supporting DSCSA-Compliant Transport?

Evaluate a transport vendor on documentation, not on compliance claims it has no basis to make. Ask how handoffs are recorded, how temperature is monitored and logged, and how quickly the vendor can produce a custody record if a distributor or dispenser needs to trace a shipment. Pillow Logistics supports pharmaceutical distribution and healthcare supply chains with exactly that kind of documented, temperature-segregated transport. Contact Pillow Logistics to talk through how a transport partner fits into your supply chain’s compliance picture.